You are here

Our science / Clinical Trials / Find a Trial / NCT02294019

Actual Use Trial of Ibuprofen 400 mg

Back to Search Print Save as PDF Bookmark Trial

NCT02294019

Last updated on May 11, 2018
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Robert's Discount Pharmacy
Hoover, Alabama, 35226 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Patient Compliance
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18+ years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male or female at least 18 years of age (19 years of age in Alabama)

- Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Current government-issued identification (ID)

- Pregnant or breastfeeding females

NCT02294019
Pfizer
Completed
Actual Use Trial of Ibuprofen 400 mg

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.
Advanced Search

Similar Trials

Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors
NCT03330405
All Genders
18+
Years
Multiple Sites
Patients With Pace Makers But no Evidence of Ischemic Heart Disease
A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade
NCT00174512
All Genders
18+
Years
Multiple Sites
Patient Compliance
Actual Use Trial of Ibuprofen 400 mg
NCT02294019
All Genders
18+
Years
Multiple Sites
Type 2 Diabetes Patients
A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients
NCT01298518
All Genders
18+
Years
Multiple Sites
Actual Use Trial of Ibuprofen 400 mg
A Multicenter Actual Use And Compliance Study Of Ibuprofen 400 Mg In A Simulated Over-the-counter Environment
This is an open label, multicenter, 30 day study designed to mimic an OTC like environment in which subjects will use the product after making a purchase decision about ibuprofen 400 mg caplets based only on their reading of the Drug Facts Label (DFL) and other information on the package.
Not Provided
Interventional
Phase 3
Masking: None (Open Label)
Patient Compliance
Drug: Ibuprofen 400 mg caplet
400 milligram (mg) caplet according to Drug Facts label
Experimental: Ibuprofen caplet arm
Intervention: Drug: Ibuprofen 400 mg caplet
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
738
May 2015
May 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male or female at least 18 years of age (19 years of age in Alabama)
  • Subject reports taking over-the-counter (OTC) analgesics for pain or fever relief

Exclusion Criteria:

  • Current government-issued identification (ID)
  • Pregnant or breastfeeding females
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT02294019
B3491013
AUT ( Other Identifier: Alias Study Number )
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
April 2016

ICMJE     Data element required by the

International Committee of Medical Journal Editors and the
World Health Organization ICTRP

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now